Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.640, 2011-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Meaningful QOL gains with alosetron in women with IBS-D
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. :
Infliximab's QOL effect clinically meaningful in rheumatic disorders
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
Ranolazine provides sustained improvements in health status and QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 551, 2008-01 ,pp. :